CRON.TO - Cronos Group Inc.
| Previous Close | 9.00 |
| Open | 9.20 |
| Bid | 9.05 x 0 |
| Ask | 9.07 x 0 |
| Day's Range | 8.77 - 9.20 |
| 52 Week Range | 5.82 - 23.67 |
| Volume | 360,038 |
| Avg. Volume | 1,092,381 |
| Market Cap | 3.16B |
| Beta (5Y Monthly) | 3.96 |
| PE Ratio (TTM) | 6.74 |
| EPS (TTM) | 1.34 |
| Earnings Date | Aug. 06, 2020 - Aug. 10, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.14 |
- Yahoo Finance
Canopy Growth CEO says new data on cannabis beverages show they can be bigger than hard seltzer
Despite recent troubles, Canopy Growth is optimistic its cannabis beverages can dwarf the growth of hard seltzers.
- Zacks
Cronos Group's Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Cronos Group.
- GlobeNewswire
Cronos Group Inc. Announces Conference Participation for June 2020
The webcasts will be available on the Investors section of the Company’s website at ir.thecronosgroup.com/events-presentations. Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.
- The Motley Fool
Turn $1,000 Into $4,000 With This Pot Stock
Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a pot stock that trades at a big discount to its cash balance. Now is the time to strike.The post Turn $1,000 Into $4,000 With This Pot Stock appeared first on The Motley Fool Canada.
- Zacks
Cronos (CRON) Looks Good: Stock Adds 8.1% in Session
Cronos (CRON) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
- The Motley Fool
If You Invested $1,000 in Cronos IPO, You Would Have Returned a Staggering $85,000 Today
Is Cronos stock a buy right now?The post If You Invested $1,000 in Cronos IPO, You Would Have Returned a Staggering $85,000 Today appeared first on The Motley Fool Canada.
- Motley Fool
Better Marijuana Stock: Aurora Cannabis vs. Cronos Group
Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 results earlier this month that were below expectations. Which of these two marijuana stocks is the better pick going forward?
- Motley Fool
Why Marijuana Stock Cronos Group Shot 8% Higher on Friday
The stock of Cronos Group (NASDAQ: CRON) ended the week on a high note, rising more than 8% on Friday to outpace the gains of the broader market. Cronos has a major CBD asset in its Lord Jones product line. Although the results of the study, conducted by researchers at the University of Lethbridge in Canada, were published last month, they are only now hitting the news media and getting on the radar of investors.
- Yahoo Finance Video
Rep. Ed Perlmutter on outlook for cannabis banking reform amid coronavirus
Colorado Representative Ed Perlmutter joins Yahoo Finance’s Zack Guzman to discuss the future of cannabis in the U.S., along with his outlook on future stimulus legislation.
- Motley Fool
These 2 Pot Stocks Have the Most Cash to Weather the Downturn
Canopy Growth and Cronos Group have more cash on hand than most other cannabis companies, but are they buys?
- The Motley Fool
Will Altria Buy Out Cronos (TSX:CRON) Stock?
Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) stock is suffering during the coronavirus bear market. Could Altria Group (NYSE:MO) buy the company?The post Will Altria Buy Out Cronos (TSX:CRON) Stock? appeared first on The Motley Fool Canada.
- Motley Fool
Here's Why Cronos Still Isn't a Buy, Despite Posting a Profit and Boasting $1 Billion in Cash
Cannabis investors sometimes have to take earnings results with a grain of salt. Relying just on sales and net income figures can lead to incorrect conclusions. Cronos has recorded a positive net income figure in each of its past five quarterly results.
- Motley Fool
Why Canopy Growth, Cronos Group, and OrganiGram Soared Today
Shares of several top Canadian cannabis producers soared today after one of their peers, Aurora Cannabis (NYSE: ACB), reported better-than-expected fiscal 2020 third-quarter revenue growth after the market closed on Thursday. Canopy Growth (NYSE: CGC) stock was up 13.4% as of 3:38 p.m. EDT on Friday, while shares of Cronos Group (NASDAQ: CRON) and OrganiGram Holdings (NASDAQ: OGI) were up 10.3% and 13.5%, respectively. Investors now appear to be increasingly optimistic that the rest of the Canadian cannabis industry could also enjoy a turn for the better after a challenging period following Aurora's surprisingly positive results.
- GlobeNewswire
Cronos Group Inc. to Hold Virtual 2020 Annual and Special Meeting of Shareholders
Due to the continued public health concerns related to the COVID-19 pandemic, to mitigate risks to the health and safety of our communities, shareholders, employees and other stakeholders, Cronos Group will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2020 Annual and Special Meeting online regardless of their geographic location, including a chance to ask questions and vote. The Company’s proxy statement describing the formal business to be conducted at the meeting and containing detailed instructions about how to participate in the meeting is available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/investor-relations.
- Motley Fool
Cronos Group Could Survive the COVID-19 Storm
With rising revenue and a strong balance sheet, Cronos Group might just be able to stay afloat amid the pandemic.
- Motley Fool
$10,000 Invested in Aurora, Canopy, Cronos, and HEXO 3 Years Ago Would Be Worth This Much Today
For years, the marijuana industry was the hottest investment on Wall Street. Over the past 13-plus months, cannabis stocks have been raked over the coals. Regulatory-based supply issues in Canada, high tax rates on legal-channel pot products in key U.S. states, and the inability of many North American pot stocks to access traditional forms of financing have quickly pulled the rug out from beneath this blazing hot industry.
- Motley Fool
Better Marijuana Stock to Buy: Cronos Group or Canopy Growth?
Over the last 20 months, they have been impacted by valuation issues, a thriving black market, lower than expected demand, high inventory levels, mounting losses, health issues from the vaping scandals, and much more. The investor euphoria that surrounded cannabis stocks when Canada legalized marijuana for recreational use seems like a distant dream. The marijuana sector is still at a nascent stage and is expected to grow at a rapid pace in the upcoming decade.
- Newsfile
FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cronos Group Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los angeles, California--(Newsfile Corp. - May 11, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cronos Group Inc. (NASDAQ: CRON) ("Cronos" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 9, 2019 and March ...
- Newsfile
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cronos Group Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - May 11, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cronos Group Inc. (NASDAQ: CRON) ("Cronos" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 9, 2019 and March 2, 2020, inclusive ...
- Newsfile
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cronos Group Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - May 10, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cronos Group Inc. ("Cronos" or "the Company") (NASDAQ: CRON) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 9, 2019 and March 2, ...
- Newsfile
2-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cronos Group Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - May 9, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cronos Group Inc. ("Cronos" or "the Company") (NASDAQ: CRON) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 9, 2019 and March 2, ...
- Motley Fool
Cronos Group Inc. (CRON) Q1 2020 Earnings Call Transcript
Thank you, Natalia and thank you for joining us today to review Cronos Group's first quarter 2020 financial and business performance. Today, I'm joined by our Chairman, President and CEO, Mike Gorenstein; our CFO, Jerry Barbato and our EVP of Legal and Regulatory Affairs, Xiuming Shum. Cronos Group issued a news release announcing our financial results this morning, which are filed on our EDGAR and SEDAR profiles.
- Motley Fool
Cronos Group Slides 3% on Q1 Results
Revenue came in under expectations, while there was a large asterisk next to the net profit line item.
- Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cronos Group Inc. (CRON)
The Law Offices of Frank R. Cruz reminds investors of the upcoming May 11, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON) securities between May 9, 2019, and March 2, 2020, inclusive (the "Class Period").
- Yahoo Finance Canada
Pot producer Cronos Group warns of COVID-19 sales impact
Cronos Group expects Canada’s cannabis market will be “choppy” for the next six months to a year as COVID-19 impacts sales channels.
